Next Article in Journal
Anti-Biofilm Activity of Assamsaponin A, Theasaponin E1, and Theasaponin E2 against Candida albicans
Previous Article in Journal
Insights into the Mechanism of Action of the Degraded Limonoid Prieurianin
Previous Article in Special Issue
Changes in Essential Fatty Acids and Ileal Genes Associated with Metabolizing Enzymes and Fatty Acid Transporters in Rodent Models of Cystic Fibrosis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Special Issue: “Recent Advances in Ion Channels and Ion Channelopathies”

by
Deanne H. Hryciw
1,2
1
School of Environment and Science, Griffith University, Nathan, QLD 4111, Australia
2
Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD 4111, Australia
Int. J. Mol. Sci. 2024, 25(7), 3598; https://doi.org/10.3390/ijms25073598
Submission received: 8 March 2024 / Revised: 18 March 2024 / Accepted: 19 March 2024 / Published: 22 March 2024
(This article belongs to the Special Issue Recent Advances in Ion Channels and Ion Channelopathies)
The aim of this special issue was to showcase recent advanced in understanding ion channel function and dysfunction associated with disease.
Ion channels play a significant role in normal homeostasis, and contribute to functions required for life such as signal transduction, transepithelial transport, regulation of neurological function and maintenance of cell volume and ion concentrations [1]. The diversity of ion channels contributes to their essential role in the maintenance of life, with researchers often limiting their focus to proteins expressed in humans. It is important to consider that studies focused on ion channels expressed in other animal phylum can inform our understanding between the structure and function of these critical transport proteins.
Chen et al. (contribution 1), investigated the α2δ subunit in the high-voltage activated (HVA) calcium channel in the sweet potato rot nematode, Ditylenchus destructor. Voltage gated calcium channels are in general classified as low-voltage activated and high-voltage activated based on their electrophysiological properties [2]. The pore forming α1 subunit, is supported by the α2δ subunit, which is critical for trafficking and glycosylaphosphhatidylinositol dependant activation of the HVA [3]. Chen et al. (contribution 1), demonstrated the voltage-gated calcium channel α2δ subunit (DdCavα2δ) in Ditylenchus destructor was critical for motility, chemotaxis and reproduction. As Ditylenchus destructor, has the potential to harm critically important range of commercial plants including carrots and peanuts, modulation of calcium channel function could be investigated in terms of agricultural benefits.
Ion channelopathies are a heterogeneous group of disorders, caused by ion channel dysfunction due to genetic or acquired factors such as drugs and toxins [4]. The most common cause of ion channelopathies are mutations specifically in genes which encode ion channels (and not accessory proteins), that lead to an impairment of ion channel function [4]. Critical to this space is the ability of a change in genetic sequence in an ion channel to be classified as benign (polymorphic) or pathogenic [5].
Neurological ion channels are likely to play a role in homeostatic mechanisms associated with membrane excitability, with ion channelopathies likely to first present in childhood [6]. One disorder, epilepsy, is often characterised by focal and generalised seizures, which may be the result of ion channel dysfunction [7]. Several epilepsy associated genes have been identified in humans, and research by Rychov et al. (contribution 2) and Mazzaferro et al. (contribution 3) demonstrate a role of K+ channel subfamily T member 1 (KCNT1) and the α4β2 neuronal nicotinic acetylcholine receptor, respectively in this disorder. Both studies identified specific genetic mutations that lead to an imbalance in neuronal excitability. Critical to this area of research is the use of electrophysiology focused on specific ion channel functioning, stemming from the seminal work from Hodgkin and Huxley [8]. The traditional electrophysiological methods, however, require analysis of mutations individually which results in very low throughput. Recent research in this space has led to the development of high-throughput sequencing and proteomics techniques, which allow for detailed analysis of disease-relevant molecular mutations in ion channels [9], which may improve diagnosis of ion channelopathies associated with genetic mutations.
Targeting ion channel dysfunction in disease is a significant area of research, with traditional drug therapies based off pharmacotherapy. Neuropathic pain is the consequence of lesions to the somatosensory nervous system that alter its structure and function, with pain occurring spontaneously via pathologically amplified activation of the somatosensory nervous system [10]. Natural products have been investigated in the treatment of neuropathic pain as they often have better biocompatibility and fewer adverse side effects [11]. The study by Yang et al. investigated the potential of the natural product Narirutin in reversing neuropathic pain (contribution 4). Narirutin modulates a number of intracellular pathways associated with apoptosis, cell cycle and cell signaling associated with oxidative stress and inflammation [12] To add to this body of research, Yang et al. identified Nav1.7 as the molecular target of Narirutin (contribution 4). Research in the field of natural products has the potential to not only identified potential therapeutic drugs, but to characterise the relationship between structure and function of an ion channel.
Cystic fibrosis (CF) is a progressive ion channelopathy caused by mutations in the CF membrane conductance regulator (CFTR) [13]. Much of our understanding of the pathological changes associated with CF has focused on lung dysfunction, however in addition, gastrointestinal dysfunction is also an important pathological feature in CF [14]. Nutritional status, because of gastrointestinal dysfunction, significantly impacts morbidity and mortality [15]. In this issue, research by Shrestha et al. (contribution 5) investigated the essential fatty acid status in a novel rat model of CF. Research in earlier mice models demonstrated that essential fatty acid status in mice models does not always mimic patients with CF [16]. Understanding the ileal genetic changes in essential fatty acid metabolic pathways in the rat model (contribution 5), may provide us with a better understanding about the pathological changes associated with CF in non-lung tissue. Interestingly, a study in the CF pig demonstrated that the essential fatty acid changes are not due to diet, as these changes exist at birth [17]. Thus, in addition to changes in cell signal transduction and transport, ion channel dysfunction may lead to imbalances in lipid metabolism.
In conclusion, ion channels are a diverse group of proteins essential to life, and understanding the relationship between structure and function through investigations in lower order organisms or natural product ligands may provide further insight into this diverse group of proteins. Using both traditional and emerging methods for analysis, the burden of differentiating polymorphism from pathogenetic mutation may be improved. Certainly these studies have contributed to the history of trailblazing theoretical and experimental research focused on ion channels [18], with the adoption of emerging novel technologies likely to contribute to this rapidly evolving field of biology.

Funding

This research received no external funding.

Conflicts of Interest

The author declares no conflict of interest.

List of Contributions

  • Chen, X.; An, M.; Ye, S.; Yang, Z.; Ding, Z. The α2δ Calcium Channel Subunit Accessorily and Independently Affects the Biological Function of Ditylenchus destructor. Int. J. Mol. Sci. 2022, 23, 12999.
  • Rychkov, G.Y.; Shaukat, Z.; Lim, C.X.; Hussain, R.; Roberts, B.J.; Bonardi, C.M.; Rubboli, G.; Meaney, B.F.; Whitney, R.; Møller, R.S.; et al. Functional Effects of Epilepsy Associated KCNT1 Mutations Suggest Pathogenesis via Aberrant Inhibitory Neuronal Activity. Int. J. Mol. Sci. 2022, 23, 15133.
  • Yang, H.; Shan, Z.; Guo, W.; Wang, Y.; Cai, S.; Li, F.; Huang, Q.; Liu, J.A.; Cheung, C.W.; Cai, S. Reversal of Peripheral Neuropathic Pain by the Small-Molecule Natural Product Narirutin via Block of Nav1.7 Voltage-Gated Sodium Channel. Int. J. Mol. Sci. 2022, 23, 14842.
  • Shrestha, N.; Rout-Pitt, N.; McCarron, A.; Jackson, C.A.; Bulmer, A.C.; McAinch, A.J.; Donnelley, M.; Parsons, D.W.; Hryciw, D.H. Changes in Essential Fatty Acids and Ileal Genes Associated with Metabolizing Enzymes and Fatty Acid Transporters in Rodent Models of Cystic Fibrosis. Int. J. Mol. Sci. 2023, 24, 7194.

References

  1. Hübner, C.A.; Jentsch, T.J. Ion channel diseases. Human. Mol. Genet. 2002, 11, 2435–2445. [Google Scholar] [CrossRef] [PubMed]
  2. Klugbauer, N.; Marais, E.; Hofmann, F. Calcium channel alpha2delta subunits: Differential expression, function, and drug binding. J. Bioenerg. Biomembr. 2003, 35, 639–647. [Google Scholar] [CrossRef]
  3. Davies, A.; Kadurin, I.; Alvarez-Laviada, A.; Douglas, L.; Nieto-Rostro, M.; Bauer, C.S.; Pratt, W.S.; Dolphin, A.C. The alpha2delta subunits of voltage-gated calcium channels form GPI-anchored proteins, a posttranslational modification essential for function. Proc. Natl. Acad. Sci. USA 2010, 107, 1654–1659. [Google Scholar] [CrossRef]
  4. Kim, J.B. Channelopathies. Korean J. Pediatr. 2014, 57, 1–18. [Google Scholar] [CrossRef] [PubMed]
  5. Ma, J.G.; Vandenberg, J.I.; Ng, C.A. Development of automated patch clamp assays to overcome the burden of variants of uncertain significance in inheritable arrhythmia syndromes. Front. Physiol. 2023, 14, 1294741. [Google Scholar] [CrossRef] [PubMed]
  6. Bartolini, E.; Campostrini, R.; Kiferle, L.; Pradella, S.; Rosati, E.; Chinthapalli, K.; Palumbo, P. Epilepsy and brain channelopathies from infancy to adulthood. Neurol. Sci. 2020, 41, 749–761. [Google Scholar] [CrossRef] [PubMed]
  7. Silva-Cardoso, G.K.; N’Gouemo, P. Seizure-suppressor genes: Can they help spearhead the discovery of novel therapeutic targets for epilepsy? Expert. Opin. Ther. Targets 2023, 27, 657–664. [Google Scholar] [CrossRef] [PubMed]
  8. Hodgkin, A.L.; Huxley, A.F. A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. 1952, 117, 500–544. [Google Scholar] [CrossRef] [PubMed]
  9. Seibertz, F.; Voigt, N. High throughput methods for cardiac cellular electrophysiology studies: The road to personalized medicine. Am. J. Physiol. Heart Circ. Physiol. 2024. [Google Scholar] [CrossRef] [PubMed]
  10. Costigan, M.; Scholz, J.; Woolf, C.J. Neuropathic pain: A maladaptive response of the nervous system to damage. Annu. Rev. Neurosci. 2009, 32, 1–32. [Google Scholar] [CrossRef] [PubMed]
  11. Dewanjee, S.; Sohel, M.; Hossain, M.S.; Ansari, F.; Islam, M.T.; Sultana, F.; Al Mamun, A.; Islam, M.M.; Amin, M.N. A comprehensive review on clinically proven natural products in the management of nerve pain, with mechanistic insights. Heliyon 2023, 9, e15346. [Google Scholar] [CrossRef] [PubMed]
  12. Pandey, P.; Khan, F.; Ramniwas, S.; Saeed, M.; Ahmad, I. A mechanistic review of the pharmacological potential of narirutin: A dietary flavonoid. Naunyn Schmiedebergs Arch. Pharmacol. 2024, 1–13. [Google Scholar] [CrossRef] [PubMed]
  13. Riordan, J.R.; Rommens, J.M.; Kerem, B.; Alon, N.; Rozmahel, R.; Grzelczak, Z.; Zielenski, J.; Lok, S.; Plavsic, N.; Chou, J.L.; et al. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 1989, 245, 1066–1073. [Google Scholar] [CrossRef] [PubMed]
  14. McDonald, C.M.; Reid, E.K.; Pohl, J.F.; Yuzyuk, T.K.; Padula, L.M.; Vavrina, K.; Altman, K. Cystic fibrosis and fat malabsorption: Pathophysiology of the cystic fibrosis gastrointestinal tract and the impact of highly effective CFTR modulator therapy. Nutr. Clin. Pract. 2024, 39 (Suppl. S1), S57–S77. [Google Scholar] [CrossRef] [PubMed]
  15. Freedman, S.D.; Blanco, P.G.; Zaman, M.M.; Shea, J.C.; Ollero, M.; Hopper, I.K.; Weed, D.A.; Gelrud, A.; Regan, M.M.; Laposata, M.; et al. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N. Engl. J. Med. 2004, 350, 560–569. [Google Scholar] [CrossRef] [PubMed]
  16. Hryciw, D.H.; Jackson, C.A.; Shrestha, N.; Parsons, D.; Donnelley, M.; McAinch, A.J. Role for animal models in understanding essential fatty acid deficiency in cystic fibrosis. Cell Mol. Life Sci. 2021, 78, 7991–7999. [Google Scholar] [CrossRef] [PubMed]
  17. Uc, A.; Strandvik, B.; Yao, J.; Liu, X.; Yi, Y.; Sun, X.; Welti, R.; Engelhardt, J.F.; Norris, A.W. The fatty acid imbalance of cystic fibrosis exists at birth independent of feeding in pig and ferret models. Clin. Sci. 2022, 136, 1773–1791. [Google Scholar] [CrossRef] [PubMed]
  18. Tóth, K. Diversity of ion channels. J. Physiol. 2021, 599, 2603–2604. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Hryciw, D.H. Special Issue: “Recent Advances in Ion Channels and Ion Channelopathies”. Int. J. Mol. Sci. 2024, 25, 3598. https://doi.org/10.3390/ijms25073598

AMA Style

Hryciw DH. Special Issue: “Recent Advances in Ion Channels and Ion Channelopathies”. International Journal of Molecular Sciences. 2024; 25(7):3598. https://doi.org/10.3390/ijms25073598

Chicago/Turabian Style

Hryciw, Deanne H. 2024. "Special Issue: “Recent Advances in Ion Channels and Ion Channelopathies”" International Journal of Molecular Sciences 25, no. 7: 3598. https://doi.org/10.3390/ijms25073598

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop